Iterum Therapeutics plc (ITRM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 390K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 20K | 696K | 342K | 0 | 0 | 8K | 7K | 440K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 5.13% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 370K | -696K | -342K | 0 | 0 | -8K | -7K | -440K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 94.87% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -8600% | -4785.71% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 7.75M | 4.83M | 3.37M | 3.67M | 4.89M | 3.98M | 6.16M | 10.99M | 16.68M | 10.82M | 8.53M | 7.93M | 7.03M | 8.05M | 7.37M | 6.83M | 4.87M | 6.99M | 5.85M | 4.64M |
| OpEx % of Revenue | 1987.69% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 6.49M | 4.18M | 2.78M | 2.12M | 1.78M | 1.9M | 2.19M | 1.69M | 1.83M | 1.86M | 2.1M | 2.09M | 2.68M | 4.07M | 3.93M | 3.13M | 3.03M | 4.27M | 3.4M | 2.29M |
| SG&A % of Revenue | 1664.36% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.26M | 649K | 591K | 1.3M | 3.11M | 2.08M | 3.97M | 9.3M | 14.85M | 8.96M | 6.43M | 5.84M | 4.35M | 3.98M | 3.44M | 3.7M | 1.84M | 2.71M | 2.45M | 2.35M |
| R&D % of Revenue | 323.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 254K | 0 | 0 | -17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.38M | -5.53M | -3.71M | -3.67M | -4.89M | -3.98M | -6.16M | -11.43M | -16.68M | -10.82M | -8.53M | -7.93M | -7.03M | -8.05M | -7.37M | -6.83M | -4.87M | -6.99M | -5.85M | -4.64M |
| Operating Margin % | -1892.82% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -51.05% | -39.06% | 39.8% | 67.89% | 70.71% | 63.26% | 27.75% | -44.22% | -137.21% | -34.43% | -15.69% | -16.06% | -44.32% | -15.21% | -26.1% | -47.05% | 23.06% | 15.34% | 54.65% | 79.96% |
| EBITDA | -7.03M | -5.18M | -3.36M | -3.41M | -4.88M | -3.97M | -6.16M | -10.99M | -16.25M | -10.38M | -8.09M | -7.49M | -6.59M | -7.59M | -6.92M | -5.06M | -4.76M | -6.8M | -5.81M | -4.61M |
| EBITDA Margin % | -1801.79% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -44.03% | -30.49% | 45.4% | 68.98% | 69.97% | 61.79% | 23.94% | -46.8% | -146.72% | -36.72% | -17.05% | -48.08% | -38.27% | -11.66% | -18.98% | -9.79% | 24.29% | 17.19% | 54.79% | 80.1% |
| D&A (Non-Cash Add-back) | 355K | 351K | 349K | 261K | 8K | 8K | 7K | 440K | 436K | 438K | 436K | 439K | 448K | 455K | 458K | 1.77M | 111K | 185K | 35K | 39K |
| EBIT | -8.41M | -6M | -4.3M | -5.68M | -5.37M | -4.39M | -6.57M | -11.81M | -3.42M | -11.73M | -9.37M | -5.07M | -29.04M | -5.63M | -2.03M | -3.24M | 4.94M | 8.9M | -95.91M | -6.92M |
| Net Interest Income | -441K | -316K | -534K | -874K | -590K | -571K | -487K | -405K | -300K | -324K | -399K | 0 | -636K | -766K | -1.04M | -772K | -849K | -980K | -2.95M | -4.24M |
| Interest Income | 0 | 133K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 441K | 449K | 534K | 874K | 590K | 571K | 487K | 405K | 300K | 324K | 399K | - | 636K | 766K | 1.04M | 772K | 849K | 980K | 2.95M | 4.24M |
| Other Income/Expense | -1.47M | -921K | -1.12M | -2.89M | -1.07M | -990K | -890K | -789K | 12.97M | -1.23M | -1.24M | 2.94M | -22.64M | 1.66M | 4.3M | 2.82M | 8.97M | 14.91M | -93.01M | -6.52M |
| Pretax Income | -8.85M | -6.45M | -4.83M | -6.56M | -5.96M | -4.97M | -7.05M | -12.22M | -3.72M | -12.06M | -9.77M | -4.99M | -29.68M | -6.39M | -3.07M | -4.01M | 4.09M | 7.92M | -98.86M | -11.16M |
| Pretax Margin % | -2268.46% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 132K | 59K | 60K | 25K | 136K | 31K | 48K | 142K | 161K | 187K | 123K | 101K | -570K | 343K | 427K | 171K | 352K | 122K | 60K | 24K |
| Effective Tax Rate % | -1.49% | -0.91% | -1.24% | -0.38% | -2.28% | -0.62% | -0.68% | -1.16% | -4.33% | -1.55% | -1.26% | -2.02% | 1.92% | -5.37% | -13.9% | -4.26% | 8.6% | 1.54% | -0.06% | -0.22% |
| Net Income | -8.98M | -6.51M | -4.89M | -6.58M | -6.09M | -5M | -7.1M | -12.36M | -3.88M | -12.24M | -9.89M | -5.09M | -29.11M | -6.74M | -3.5M | -4.18M | 3.74M | 7.8M | -98.92M | -11.19M |
| Net Margin % | -2302.31% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -47.34% | -30.26% | 31.12% | 46.76% | -57.18% | 59.18% | 28.19% | -142.87% | 86.68% | -81.78% | -182.54% | -21.71% | -878.11% | -186.37% | 96.46% | 62.61% | 130.67% | 162.28% | -514.42% | 52.68% |
| Net Income (Continuing) | -8.98M | -6.51M | -4.89M | -6.58M | -6.09M | -5M | -7.1M | -12.36M | -3.88M | -12.24M | -9.89M | -5.09M | -29.11M | -6.74M | -3.5M | -4.18M | 3.74M | 7.8M | -98.92M | -11.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -0.16 | -0.14 | -0.25 | -0.30 | -0.30 | -0.46 | -0.94 | -0.30 | -0.95 | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 | -0.34 | 0.28 | 0.55 | -11.20 | -4.13 |
| EPS Growth % | 33.33% | 46.67% | 69.57% | 73.4% | 0% | 68.42% | 41.03% | -129.27% | 87.39% | -72.73% | -168.97% | -20.59% | -950% | -200% | 97.41% | 91.77% | 103.37% | 104.97% | 25.03% | 81.22% |
| EPS (Basic) | -0.20 | -0.16 | -0.14 | -0.25 | -0.30 | -0.30 | -0.46 | -0.94 | -0.30 | -0.95 | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 | -0.34 | 0.29 | 0.60 | -12.21 | -4.13 |
| Diluted Shares Outstanding | 45.8M | 39.94M | 34.06M | 19.7M | 20.04M | 16.55M | 15.43M | 13.18M | 13.04M | 12.94M | 12.68M | 13.34M | 12.23M | 12.22M | 12.19M | 13.22M | 13.48M | 13.64M | 8.1M | 2.71M |
| Basic Shares Outstanding | 45.8M | 39.94M | 34.06M | 19.7M | 20.04M | 16.55M | 15.43M | 13.18M | 13.04M | 12.94M | 12.68M | 13.34M | 12.23M | 12.22M | 13.23M | 13.22M | 12.18M | 13.02M | 8.79M | 2.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |